VESIGEN THERAPEUTICS
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables the delivery of a wide range of payloads, including RNAs (mRNA, shRNA, ribozymes), proteins (signaling proteins, enzymes, antibody fragments), and gene-editing complexes (Cas9/gRNA) directly into the cytoplasm of target cells, expanding the universe of druggable targets.
VESIGEN THERAPEUTICS
Industry:
Biotechnology Therapeutics
Founded:
2019-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.vesigentx.com
Total Employee:
1+
Status:
Active
Total Funding:
28.5 M USD
Technology used in webpage:
SPF Google Maps Microsoft Exchange Online Google Office 365 Mail Google Cloud Gravity Forms Akismet Akismet Non Hosted CloudFloorDNS
Similar Organizations
CAMP4 Therapeutics
CAMP4 Therapeutics is a biotechnology company that uses RNA to restore healthy gene expression.
Cedilla Therapeutics
Cedilla Therapeutics is a biotechnology company that develops targeted small molecules for the treatment of cancer and other diseases.
Disarm Therapeutics
Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.
Elevai Labs
Elevai Labs is a biotechnology company that develops regenerative skin care applications.
Nutcracker Therapeutics
Nutcracker Therapeutics is a biotech company that develops mRNA therapeutics.
Rectify Pharmaceuticals
Rectify Pharmaceuticals is a biotechnology company developing Positive Functional Modulators (PFMs), disease-modifying therapeutics.
Reservoir Neuroscience
Reservoir Neuroscience is a biopharma company that develops novel therapeutics.
Tango Therapeutics
Tango Therapeutics is a biotechnology company that is developing next generation cancer therapies.
Vigil Neuroscience
Vigil Neuroscience is a biotechnology company that develops novel therapeutics for neurodegenerative diseases.
Current Advisors List
Current Employees Featured
Founder
Investors List
FARA
FARA investment in Grant - Vesigen Therapeutics
Linden Lake Ventures
Linden Lake Ventures investment in Series A - Vesigen Therapeutics
Alexandria Venture Investments
Alexandria Venture Investments investment in Series A - Vesigen Therapeutics
Morningside Venture Investments
Morningside Venture Investments investment in Series A - Vesigen Therapeutics
Leaps by Bayer
Leaps by Bayer investment in Series A - Vesigen Therapeutics
Key Employee Changes
| Date | New article |
|---|---|
| 2022-04-11 | Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive Officer |
Official Site Inspections
http://www.vesigentx.com
- Host name: 147.61.127.34.bc.googleusercontent.com
- IP address: 34.127.61.147
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Vesigen Therapeutics"
Vesigen | ARRDC1 Mediated Microvesicles (ARMMs) | Intracellular ...
Vesigen is engineering a non-viral technology platform to deliver RNA, proteins, and gene-editing complexes to specific tissues and cell types—including those that have been hard to target.See details»
Vesigen Therapeutics - Crunchbase Company Profile
Vesigen Therapeutics is a biotechnology company that develops groundbreaking therapeutic products. Our patented technology, called ARMMs (ARRDC1 Mediated Microvesicles), enables the delivery of a wide range of payloads, …See details»
Leaps by Bayer
Expanding the universe of druggable targets. Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery technology.See details»
Vesigen Therapeutics, Inc. | LinkedIn
Delivering intracellular therapeutics with ARMMed microvesicles | Vesigen is developing groundbreaking therapeutic products directed to intracellular targets using a scalable and extracellular...See details»
Vesigen Therapeutics - Overview, News & Similar companies
Dec 19, 2023 · View Vesigen Therapeutics (www.vesigentx.com) location in Massachusetts, United States , revenue, industry and description. Find related and similar companies as well …See details»
Vesigen Therapeutics, Inc. Information - RocketReach
Vesigen Therapeutics, Inc. is a Biotechnology Research, Drug Delivery, and Biotechnology company located in Cambridge, Massachusetts with 42 employees. Find top employees, …See details»
Vesigen Therapeutics Presents Data on Recent Advances to its …
CAMBRIDGE, Mass., May 18, 2021 /PRNewswire/ -- Vesigen Therapeutics, Inc., a biotechnology company pioneering development of a novel extracellular vesicle-mediated delivery platform, …See details»
Vesigen Therapeutics Appoints Paulash Mohsen as …
Apr 11, 2022 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )--Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology, ARMMs, today announced the appointment of...See details»
Drug Delivery - Morningside
Delivering Therapies to Previously Undruggable Targets. Vesigen’s patented technology uses ARRDC1 Mediated Microvesicles—or ARMMs—to deliver a range of payloads to previously …See details»
Vesigen Therapeutics - VentureRadar
Website: https://www.vesigentx.com/ Vesigen’s patented technology uses ARRDC1 Mediated Microvesicles—or ARMMs—to deliver a range of payloads to previously undruggable targets.See details»
Vesigen Therapeutics launches with USD 28.5 million Series A
Jul 22, 2020 · Vesigen is developing a novel delivery technology that addresses this hurdle and opens new pathways to transformative treatment options for patients.See details»
Vesigen Therapeutics Announces Issuance of U.S. Patent for Broad ...
CAMBRIDGE, Mass., March 16, 2021 /PRNewswire/ -- Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology to develop …See details»
Vesigen Therapeutics Presents at 3rd Exosome-Based Therapeutic ...
Nov 16, 2021 · Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery …See details»
Vesigen Therapeutics Launches with USD 28.5 Million ... - Business …
Jul 22, 2020 · Vesigen Therapeutics is a biotechnology company advancing groundbreaking therapies directed to intracellular targets using a fusogenic extracellular vesicle delivery …See details»
Press Release Service: Vesigen Therapeutics Awarded Grant from ...
Mar 14, 2023 · Vesigen will evaluate its proprietary technology to deliver CRISPR-Cas genome editing complexes as a non-viral disease-modifying strategy for patients diagnosed with the …See details»
Gang Hao Email & Phone Number | Vesigen Therapeutics, Inc. Vice ...
Looking for a different Gang Hao? Find contact details for 700 million professionals. Get Gang Hao's email address (g******@vesigentx.com) and phone number (917981....) at …See details»
Vesigen Therapeutics Appoints Paulash Mohsen as Chief
Apr 11, 2022 · CAMBRIDGE, Mass.-- ( BUSINESS WIRE )-- Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology, ARMMs, …See details»
Vesicants | CTTL | CDC - Centers for Disease Control and Prevention
May 23, 2024 · Vesicants, or "blister agents," are human-made chemical warfare agents that cause blistering of the skin and mucous membranes on contact. These agents can be spread …See details»
Vesigen Therapeutics Appoints Paulash Mohsen as Chief Executive …
Apr 11, 2022 · CAMBRIDGE, Mass.-- (BUSINESS WIRE)--Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology, ARMMs, …See details»
Vesigen Therapeutics Appoints Paulash Mohsen as CEO
CAMBRIDGE, Mass.– (BUSINESS WIRE)– Vesigen Therapeutics, Inc., a biotechnology company pioneering a novel extracellular vesicle delivery technology, ARMMs, today announced the …See details»